Biological Information
Background Information:
Glutamate is the major excitatory transmitter in the mammalian central nervous system. The receptor amino acid sequences lie in the same superfamily as GABA, glycine, serotonin 5-HT₃, and nicotinic acetylcholine, within the general class of ligand-gated ion channels. Glutamate receptors are classified functionally as ligand-gated ion channels (“ionotropic”) or as “metabotropic” receptors coupled via GTP-binding proteins. The ligand-gated ion channels contain an integral cation channel that gate Na⁺ and in some cases Ca²⁺. Glutamate NMDA Agonist receptor agonism may cause convulsions and neurodegeneration. Glutamate NMDA Agonist receptor antagonism may be anticonvulsant and neuroprotective.
Family:
Ion Channel
Sub Family:
Glutamate (Ionotropic)
Class:
Ligand-Gated
Protein Name:
GluN1/ GluN2A
Uniprot Number:
Q05586/ Q12879
Protein Aliases:
N-methyl-D-aspartate receptor subunit NR1 (NMD-R1)/ N-methyl D-aspartate receptor subtype 2A (NMDAR2A; NR2A; hNR2A)
Gene Name:
GRIN1/ GRIN2A
Gene ID:
2902/2903
Gene Aliases:
GluN1/ GluN2A
Organism:
Human
Assay Information
Assay Type:
Biochemical
Assay Sub Type:
Binding
Detection Method:
Radiometry
Measured Response:
Scintillation
Testing Information
Procedure Summary:
This assay measures the binding of [³H]CGP-39653 to glutamate NR2A receptors. Human recombinant glutamate NR1/NR2A receptors expressed in HEK293 cells are used in Tris-HCl pH 7.4 buffer. A 0.04 mg‡ aliquot of membrane is incubated with 5 nM [³H]CGP-39653 for 120 minutes at 4℃. Non-specific binding is estimated in the presence of 1 mM L-Glutamic Acid. Membranes are filtered and washed 4 times, and the filters are counted to determine [³H]CGP-39653 specifically bound. Compounds are screened at 10 µM.
Note: ‡Membrane protein may change from lot to lot; the concentration used will be adjusted if necessary.
Ligand:
[³H] CGP-39653
Ligand Kd (nM):
9.7
Ligand Concentration:
5 nM
Non Specific:
1000 µM L-Glutamic acid
Incubation:
120 min at 4°C
Control Inhibitor:
L-glutamic acid
Criteria For Significance:
≥ 50% of max stimulation or inhibition
Test Concentration / Dose:
Suggested concentration for initial testing is 10 uM
Test Sample Requirements:
Minimum for 1) Screen: 25 μl of 10 mM stock -OR- 1 mg (pre-weighed). 2) Dose Response: 60 μl of 10 mM stock -OR- 1 mg (pre-weighed).
Minimum Order Quantity:
2
Turnaround Time
Standard:
15 Business Days
Reference Compound Data
Clinical Relevance
Therapeutic Area:
CNS/Addiction/Pain
Additional Information
Brand:
LeadHunter
Testing Location:
Taiwan - Taipei
RELATED SOLUTIONS